July Open Day (2014) - UCL Division of Psychiatry
- Are you interested in studying in the Division of Psychiatry at UCL?
- Have you been offered a place on or do you plan to apply for the new MSc in Mental Health Sciences Research or MSc in Clinical Mental Health Sciences?
- Would you
like to meet some of the course staff on our new MScs?
- Would you like to hear some more details about the modules on our new MScs?
The event will be taking place on 21st July between 13.30 and 17.00.
We will be holding this event at the School of Slavonic and East European Studies building at 16 TAVITON STREET, LONDON, WC1H 0BW – room 347
Current Research in Psychosis
The aim of this optional single module is for students to develop an advanced understanding of the current main questions in research on psychosis and bipolar disorder, spanning biological, psychological and social approaches to research. This will provide foundations for students to embark on research in this area, and/or to practice clinically in a way that is directly informed by current research.
The course will be taught over 6 half day sessions, accompanied by Moodle online materials and relevant sessions in the MSc journal club.
The main topics covered by this module are:
- Defining psychosis and bipolar disorder: current models of symptoms and syndromes
- High risk mental states: current models of identification and treatment.
- The genetics of psychosis: implications for aetiology and treatment.
- Understanding and applying neurocognitive research in psychosis.
- Neuroimaging research in psychosis: current status and potential clinical applications.
- Psychopharmacology in psychosis: mechanisms and outcomes
- Psychological interventions in psychosis: models and outcomes.
- Social epidemiology of psychosis and implications for interventions.
- Experiences of psychosis and recovery: service user perspectives
The intended learning outcomes are:
- Students will be able to appraise papers based on biological, psychological and social approaches to research on psychosis and bipolar disorder, and to explain how these perspectives may be integrated.
- Students will be able to suggest approaches to managing bipolar disorder and psychosis and high risk states for transition to psychosis that are based on an up-to-date understanding of research findings in these fields.
- Students will be able to identify the key questions motivating current research on the aetiology and management of psychosis and bipolar disorder and to explain how these are being addressed.
- Students will be able to suggest ways of addressing research questions relating to the aetiology and management of psychosis and bipolar disorder.
Sonia Johnson and Elvira Bramon will lead this module. Other teachers from within and outside the Division of Psychiatry will also be involved.
Professor Sonia Johnson
Sonia Johnson is Professor of
Social and Community Psychiatry at UCL and Consultant Psychiatrist in the
Islington Early Intervention Service for psychosis. Her research interests are
in investigating what types of treatments and services work best for people
with significant mental health problems. Areas in which she has published
include acute care, including alternatives to admission, early intervention in
psychosis, employment and mental health, and services for women. She is
currently leading two major studies funded by the National Institute for Health
Research: the CORE programme, which aims to optimise crisis team care () and
the CIRCLE study, a trial of a new intervention for cannabis use in early
psychosis. She is the Course Director of the MSc in Mental Health Sciences
Research, and the MSc in Clinical Mental Health Sciences, and previously led
the part-time UCL MSc in Psychiatric Research.
Dr Elvira Bramon
Elvira Bramon held several posts at the Institute of Psychiatry before coming to UCL as a Reader in Biological Psychiatry in 2012. Her particular interests are in biological markers of psychosis and psychosis risk, including applying EEG technology to investigating psychosis risk. She is also interested in pharmacogenomics, especially for antipsychotic and mood stabilising drugs. Her post is shared with the Institute of Cognitive Neuroscience at UCL and her clinical work is on an acute inpatient ward in Camden and Islington NHS Foundation Trust.
Page last modified on 01 jul 14 11:07